webleads-tracker

Home  >  MEDTECH  > Fluidigm introduces fast 192.24 dynamic array™ IFC for ...
  >  MEDTECH TECHNO
May 17th, 2011
 
Fluidigm introduces fast 192.24 dynamic array™ IFC for genotyping
 
Fluidigm Corporation (NASDAQ:FLDM) introduced its 192.24 Dynamic Array™ IFC, designed to genotype 192 samples against 24 SNP assays in a single run, providing 4,608 data points in just one hour.
Send to a friend

The 192.24 integrated fluidic circuit (IFC) has immediate applicability in agricultural biotechnology and genome wide association studies.

Fluidigm’s latest integrated fluidic circuit features an innovative design that greatly increases sample throughput for common SNP genotyping applications. Using the new Fluidigm IFC Controller RX, the new Dynamic Array IFC enables sample loading within 30 minutes, and thermal cycling in another 30 minutes, resulting in a greatly accelerated workflow. The power to deliver 4,608 data points in one hour makes the Fluidigm system the fastest commercially practical genotyping solution in the industry today. The 192.24 Dynamic Array chip addresses the high throughput needs of genotyping by providing a four-fold increase in sample throughput when compared to the 48.48 Dynamic Array IFC. 

192.24 IFC


192.24 IFC


This accelerated workflow and increased throughput enables more data points, while the 192.24 chip retains Fluidigm’s 99.75 percent or greater call accuracy and 99 percent or greater call rates. The new chip can be read using either the BioMark™ HD or EP1™ Systems.

“The Fluidigm 192.24 Dynamic Array chip enables life science researchers to achieve ultra-low cost, and rapid throughput while maintaining full assay and reagent flexibility. Providing the ability to use fewer SNP assays, and run a high number of samples is a format that is ideal for some applications in Ag-Bio and for GWAS follow-up studies,” said Gajus Worthington, Fluidigm president and chief executive officer.

The 192.24 is particularly suited to take advantage of Fluidigm’s new SNPtype™ Assays for genotyping. While the 192.24 Dynamic Array chip will support all industry-standard assays, SNPtype Assays offer a low-cost SNP genotyping solution, are made on-demand, and are ready to meet high-throughput needs for a wide range of agricultural applications and confirmation of next-generation sequencing results.

Fluidigm IFCs, including the 192.24 chip, use just microliters of materials, allowing scientists to achieve comprehensive genetic profiling from miniscule amounts of sample. Each reaction chamber in the 192.24 chip requires only eight nanoliters of material. In addition, all Fluidigm Dynamic Array IFCs feature a matrix-style architecture that automatically assembles every possible reaction between the samples and the assays providing up to 99 percent fewer pipetting steps than needed when using 384-well plates.

About Fluidigm
Fluidigm (NASDAQ:FLDM) develops, manufactures and markets microfluidic systems for growth markets in the life science and agricultural biotechnology, or Ag-Bio, industries. Fluidigm’s proprietary microfluidic systems consist of instruments and consumables, including integrated fluidic circuits, or chips, and reagents. These systems are designed to significantly simplify experimental workflow, increase throughput and reduce costs, while providing the excellent data quality demanded by customers. Fluidigm actively markets three microfluidic systems including nine different commercial chips to leading pharmaceutical and biotechnology companies, academic institutions and Ag-Bio companies.

 
More MEDTECH TECHNO news

Jul 20th
Jul 20th
Jul 20th
Jun 30th
Jun 30th
 
©2007 Yole Developpement All rights reserved                  Disclaimer | Legal notice | To advertise
Yole Développement: Le Quartz, 75 cours Emile Zola, 69100 Villeurbanne, France. TEL: (33) 472 83 01 80 FAX: (33) 472 83 01 83 E-Mail: info @yole.fr